More than 300 news organizations, including CBS and Forbes, quoted Abt’s Lauren Olsho explaining the benefits of our PROTECT study for the CDC, which gathers and tests nasal swabs weekly from children, regardless of whether they had COVID-19 symptoms. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” said Olsho, the study’s principal investigator. Other pediatric vaccine studies captured only symptomatic cases, and with more home testing, studies like Abt’s are needed for a comprehensive view of vaccine effectiveness, she noted.
Read More
COVID-19 in North America
Potomac Officers Club AI Summit 2026
Abt delivers AI that agencies can use now, mission-ready solutions that support responsible adoption, operational fit, and measurable results.
Society for Benefit Cost Analysis (SBCA) Annual Conference 2026
Meet Abt at SBCA 2026 to discuss how rigorous economic evidence can guide environmental and public policy decisions.
2026 Health Information and Management Systems Society (HIMSS) Global Health Conference
Abt is heading to Las Vegas to meet health agencies and tech partners reshaping how public programs use data for better decisions, faster insight, and stronger outcomes for the people they serve.
Association of Maternal and Child Health Programs (AMCHP) Annual Meeting
Our experts will bring together state and local leaders at AMCHP to explore how strategic investments can strengthen maternal and child health infrastructure, improve outcomes, and build lasting partnerships.